Advertisement
s sridhar

S Sridhar

With the global pandemic and various other outbreaks, there is a renewed focus for the pharmaceutical companies to come up with new drugs, new chemical entities and/ or new biological entities (NBEs) to combat such outbreaks.

Budget 2022: Key expectations of healthcare and pharma industry

by S Sridhar |Jan 30, 2022

It is crucial for public and private entities across the pharma and healthcare value chain to collectively work towards making the sector future ready and the Union Budget 2022 is the first step in th...